Obesity, aromatase and breast cancer

Expert Review of Endocrinology and Metabolism

Volumn 6, Issue 3, 2011, Pages 383-395

  Simpson, Evan R ^a   Brown, Kristy A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

adipose; AMPK; aromatase; breast cancer; CRTC2; LKB1; metformin; obesity; PGE2; TNF

Indexed keywords

AROMATASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; PROSTAGLANDIN E2; PROTEIN KINASE LKB1; TAMOXIFEN;

ADIPOCYTE; ADIPOSE TISSUE; BODY MASS; BREAST CANCER; BREAST DUCT; BREAST REDUCTION; CANCER HORMONE THERAPY; CANCER RISK; CANCER SURGERY; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; HUMAN; LIPOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 79956144645     PISSN: 17446651     EISSN: 17448417     Source Type: Journal    
DOI: 10.1586/eem.11.35     Document Type: Review

References (85)

1. Bulun SE, Takayama K, Suzuki T, Sasano H, Yilmaz B, Sebastian S. Organization of the human aromatase p450 (CYP19) gene. Semin. Reprod. Med. 22(1), 5-9 (2004). (Pubitemid 38524579)
2. Simpson ER, Mahendroo MS, Means GD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15(3), 342-355 (1994). (Pubitemid 24180792)
3. Michael MD, Kilgore MW, Morohashi K, Simpson ER. Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J. Biol. Chem. 270(22), 13561-13566 (1995).
4. Honda S, Harada N, Takagi Y. Novel exon 1 of the aromatase gene specific for aromatase transcripts in human brain. Biochem. Biophys. Res. Commun. 198(3), 1153-1160 (1994). (Pubitemid 24172817)
5. Mahendroo MS, Means GD, Mendelson CR, Simpson ER. Tissuespecific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J. Biol. Chem. 266(17), 11276-11281 (1991). (Pubitemid 21906943)
6. Mahendroo MS, Mendelson CR, Simpson ER. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J. Biol. Chem. 268(26), 19463-19470 (1993). (Pubitemid 23270727)
7. Zhou D, Clarke P, Wang J, Chen S. Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells. J. Biol. Chem. 271(25), 15194-15202 (1996). (Pubitemid 26195000)
8. Harada N. A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochem. Biophys. Res. Commun. 189(2), 1001-1007 (1992). (Pubitemid 23032474)
9. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, Simpson ER. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J. Clin. Endocrinol. Metab. 53(2), 412-417 (1981). (Pubitemid 13250304)
10. Oz OK, Millsaps R, Welch R, Birch J, Zerwekh JE. Expression of aromatase in the human growth plate. J. Mol. Endocrinol. 27(2), 249-253 (2001). (Pubitemid 32970691)
11. Roselli CE, Resko JA. Cytochrome P450 aromatase (CYP19) in the non-human primate brain: distribution, regulation, and functional significance. J. Steroid Biochem. Mol. Biol. 79(1-5), 247-253 (2001). (Pubitemid 34158801)
12. Sasano H, Takashashi K, Satoh F, Nagura H, Harada N. Aromatase in the human central nervous system. Clin. Endocrinol. (Oxf.) 48(3), 325-329 (1998). (Pubitemid 28137645)
13. Stoffel-Wagner B, Watzka M, Schramm J, Bidlingmaier F, Klingmuller D. Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J. Steroid Biochem. Mol. Biol. 70(4-6), 237-241 (1999). (Pubitemid 29528435)
14. Calzada-Mendoza CC, Sanchez EC, Campos RR, et al. Differential aromatase (CYP19) expression in human arteries from normal and neoplasic uterus: an immunohistochemical and in situ hybridization study. Front. Biosci. 11, 389-393 (2006). (Pubitemid 43253501)
15. Madej P, Plewka A, Plewka D, et al. The aromatase expression in myomas and myometriums of women in reproduction and perimenopausal age. Folia Histochem. Cytobiol. 47(3), 497-504 (2009).
16. Attar E, Tokunaga H, Imir G, et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J. Clin. Endocrinol. Metab. 94(2), 623-631 (2009).
17. Corpechot C, Synguelakis M, Talha S, et al. Pregnenolone and its sulfate ester in the rat brain. Brain Res. 270(1), 119-125 (1983). (Pubitemid 13060692)
18. Berrino F, Muti P, Micheli A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J. Natl Cancer Inst. 88(5), 291-296 (1996). (Pubitemid 26073374)
19. Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br. J. Cancer 76(3), 401-405 (1997). (Pubitemid 27308094)
20. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl Cancer Inst. 87(3), 190-197 (1995).
21. Haynes BP, Straume AH, Geisler J, et al. Intratumoral estrogen disposition in breast cancer. Clin. Cancer Res. 16(6), 1790-1801 (2010).
22. Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr. Cancer 45(1), 1-16 (2003). (Pubitemid 36736886)
23. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J. Natl Cancer Inst. 95(16), 1218-1226 (2003). (Pubitemid 37069552)
24. Kusano AS, Trichopoulos D, Terry KL, Chen WY, Willett WC, Michels KB. A prospective study of breast size and premenopausal breast cancer incidence. Int. J. Cancer 118(8), 2031-2034 (2006).
25. Miller WR, O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids 50(4-6), 537-548 (1987).
26. Larionov AA, Berstein LM, Miller WR. Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues. J. Steroid Biochem. Mol. Biol. 81(1), 57-64 (2002). (Pubitemid 34790230)
27. Vachon CM, Sasano H, Ghosh K, et al. Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Res. Treat. 125(1), 243-252 (2010).
28. Ghosh S, Hu Y, Li R. Cell density is a critical determinant of aromatase expression in adipose stromal cells. J. Steroid Biochem. Mol. Biol. 118(4-5), 231-236 (2010).
29. Bulun SE, Sharda G, Rink J, Sharma S, Simpson ER. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. J. Clin. Endocrinol. Metab. 81(3), 1273-1277 (1996). (Pubitemid 26084463)
30. Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab. 77(6), 1622-1628 (1993). (Pubitemid 24000924)
31. O'Neill JS, Elton RA, Miller WR. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br. Med. J. (Clin. Res. Ed.) 296(6624), 741-743 (1988). (Pubitemid 18066503)
32. Harada N, Utsumi T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc. Natl Acad. Sci. USA 90(23), 11312-11316 (1993). (Pubitemid 23354419)
33. Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endocrinol. Metab. 81(11), 3843-3849 (1996). (Pubitemid 26380384)
34. Zhou D, Zhou C, Chen S. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells. J. Steroid Biochem. Mol. Biol. 61(3-6), 273-280 (1997). (Pubitemid 27455689)
35. Irahara N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-a, IL-6 and COX-2 mRNAs in human breast cancer. Int. J. Cancer 118(8), 1915-1921 (2006).
36. Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J. Clin. Endocrinol. Metab. 82(1), 70-74 (1997). (Pubitemid 27021272)
37. Zhao Y, Agarwal VR, Mendelson CR, Simpson ER. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137(12), 5739-5742 (1996). (Pubitemid 26423150)
38. Richards JA, Brueggemeier RW. Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J. Clin. Endocrinol. Metab. 88(6), 2810-2816 (2003). (Pubitemid 36724460)
39. Zhao Y, Nichols JE, Valdez R, Mendelson CR, Simpson ER. Tumor necrosis factor-a stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol. Endocrinol. 10(11), 1350-1357 (1996).
40. Clyne CD, Speed CJ, Zhou J, Simpson ER. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem. 277(23), 20591-20597 (2002). (Pubitemid 34967360)
41. Safi R, Kovacic A, Gaillard S, et al. Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor g coactivator-1a on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy. Cancer Res. 65(24), 11762-11770 (2005). (Pubitemid 41821738)
42. Clyne CD, Kovacic A, Speed CJ, Zhou J, Pezzi V, Simpson ER. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue. Mol. Cell Endocrinol. 215(1-2), 39-44 (2004). (Pubitemid 38333241)
43. Chen S, Ye J, Kijima I, Kinoshita Y, Zhou D. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue. J. Steroid Biochem. Mol. Biol. 95(1-5), 17-23 (2005). (Pubitemid 41137289)
44. Bouchard MF, Taniguchi H, Viger RS. Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells. Endocrinology 146(11), 4905-4916 (2005). (Pubitemid 41446629)
45. Chen D, Reierstad S, Lin Z, et al. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts. Cancer Res. 67(18), 8914-8922 (2007). (Pubitemid 47437469)
46. Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simpson ER. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J. Biol. Chem. 270(27), 16449-16457 (1995).
47. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. (Lond.) 33(1), 54-66 (2009).
48. World Health Organization. Fact sheet no. 311. Obesity and overweight. World Health Organization, Geneva, Switzerland (2006).
49. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu. Rev. Med. 61, 301-316 (2010).
50. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes. Rev. 4(3), 157-173 (2003). (Pubitemid 36950578)
51. Choi JH, Banks AS, Estall JL, et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARg by Cdk5. Nature 466(7305), 451-456 (2010).
52. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 5(3), 153-165 (2004). (Pubitemid 38998240)
53. Wu MH, Chou YC, Chou WY, et al. Circulating levels of leptin, adiposity and breast cancer risk. Br. J. Cancer 100(4), 578-582 (2009).
54. Ray A, Nkhata KJ, Cleary MP. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int. J. Oncol. 30(6), 1499-1509 (2007).
55. Catalano S, Marsico S, Giordano C, et al. Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J. Biol. Chem. 278(31), 28668-28676 (2003). (Pubitemid 36935773)
56. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr. Relat. Cancer 14(2), 189-206 (2007). (Pubitemid 47242622)
57. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 345(1), 271-279 (2006).
58. Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM, Rasmussen M, Richelsen B. Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity 14(1), 28-35 (2006). (Pubitemid 46214772)
59. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8(11), 1288-1295 (2002). (Pubitemid 35373562)
60. Steinberg GR, Macaulay SL, Febbraio MA, Kemp BE. AMP-activated protein kinase -the fat controller of the energy railroad. Can. J. Physiol. Pharmacol. 84(7), 655-665 (2006). (Pubitemid 44897886)
61. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 100(3), 328-341 (2007).
62. Hurley RL, Barre LK, Wood SD, et al. Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J. Biol. Chem. 281(48), 36662-36672 (2006). (Pubitemid 46042133)
63. Conkright MD, Canettieri G, Screaton R, et al. TORCs: transducers of regulated CREB activity. Mol. Cell 12(2), 413-423 (2003). (Pubitemid 37238928)
64. Koo SH, Flechner L, Qi L, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437(7062), 1109-1111 (2005).
65. Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM. The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin. Cancer Res. 8(7), 2085-2090 (2002). (Pubitemid 34753577)
66. Bardeesy N, Sinha M, Hezel AF, et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419(6903), 162-167 (2002). (Pubitemid 35025443)
67. Zhang WB, Wang Z, Su F, et al. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. J. Biol. Chem. 285(52), 40461-40471 (2010).
68. Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134(3), 451-460 (2008).
69. Ashizawa N, Yahata T, Quan J, Adachi S, Yoshihara K, Tanaka K. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol. Oncol. 119(1), 65-69 (2010).
70. Bulun SE, Rosenthal IM, Brodie AM, et al. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. J. Clin. Endocrinol. Metab. 78(2), 1616-1621 (1994). (Pubitemid 2056003)
71. Mehenni H, Gehrig C, Nezu J, et al. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am. J. Hum. Genet. 63(6), 1641-1650 (1998). (Pubitemid 30415726)
72. Brown KA, McInnes KJ, Hunger NI, Oakhill JS, Steinberg GR, Simpson ER. Subcellular localization of cyclic AMPresponsive element binding proteinregulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women. Cancer Res. 69(13), 5392-5399 (2009).
73. Brown KA, Simpson ER. Obesity and breast cancer: progress to understanding the relationship. Cancer Res. 70(1), 4-7 (2010).
74. Khan QJ, O'Dea AP, Sharma P. Musculoskeletal adverse events associated with adjuvant aromatase inhibitors. J. Oncol. DOI: 10.1155/2010/654348 (2010) (Epub ahead of print).
75. Bender CM, Sereika SM, Brufsky AM, et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 14(6), 995-998 (2007). (Pubitemid 350098658)
76. Cazzaniga M, Bonanni B, Guerrieri-Gonzaga A, Decensi A. Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol. Biomarkers Prev. 18(3), 701-705 (2009).
77. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503), 1304-1305 (2005). (Pubitemid 40813563)
78. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108(8), 1167-1174 (2001). (Pubitemid 32995375)
79. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275(1), 223-228 (2000). (Pubitemid 30038975)
80. Brown KA, Hunger NI, Docanto M, Simpson ER. Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase. Breast Cancer Res. Treat. 123(2), 591-596 (2010).
81. Goodwin PJ, Stambolic V, Lemieux J, et al. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res. Treat. 126(1), 215-220 (2011).
82. Gonzalez-Angulo AM, Meric-Bernstam F. Metformin: a therapeutic opportunity in breast cancer. Clin. Cancer Res. 16(6), 1695-1700 (2010).
83. Martin-Castillo B, Dorca J, Vazquez-Martin A, et al. Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinicaltranslational research experience at the Catalan Institute of Oncology. Ann. Oncol. 21(1), 187-189 (2010).
84. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J. Gen. Physiol. 8, 519-530 (1927).
85. Clinicaltrials.gov: Search of breast cancer AND metformin: list results www.clinicaltrials.gov/ct2/results?term=br east+cancer+AND+metformin